Skip to main content

Published locations for FDA approves trastuzumab-deruxtecan for HER2-low breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves trastuzumab-deruxtecan for HER2-low breast cancer

User login

  • Reset your password
  • /content/fda-approves-trastuzumab-deruxtecan-her2-low-breast-cancer
  • /fedprac/article/256867/metastatic-breast-cancer/fda-approves-trastuzumab-deruxtecan-her2-low-breast
  • /internalmedicinenews/article/256867/metastatic-breast-cancer/fda-approves-trastuzumab-deruxtecan
  • /oncologypractice/article/256867/metastatic-breast-cancer/fda-approves-trastuzumab-deruxtecan-her2
  • /hematology-oncology/article/256867/metastatic-breast-cancer/fda-approves-trastuzumab-deruxtecan-her2
  • /internalmedicine/article/256867/metastatic-breast-cancer/fda-approves-trastuzumab-deruxtecan-her2
  • /breast-cancer-icymi/article/256867/metastatic-breast-cancer/fda-approves-trastuzumab-deruxtecan-her2